Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.750
-0.140-2.38%
Volume:10.32M
Turnover:58.87M
Market Cap:9.18B
PE:-18.27
High:5.890
Open:5.890
Low:5.500
Close:5.890
52wk High:13.150
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.17
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.08
PE(LYR):-18.27
PS:18.49

Loading ...

Cstone Pharmaceuticals - Enters Exclusive Commercialization Agreement with Arrotex for Sugemalimab in Australia and New Zealand

THOMSON REUTERS
·
Jun 25

CStone Pharma buys back 0.50 million shares on 24 June; cumulative un-cancelled repurchases reach 3.84 million

Bulletin Express
·
Jun 24

CStone Pharmaceuticals-B Executes Share Buyback, Spending HK$2.4 Million

Stock News
·
Jun 24

Cstone Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 24

CStone Pharmaceuticals: All AGM Resolutions Secure Shareholder Approval; CEO Equity Incentive Plan Backed by 86.94% of Votes

Bulletin Express
·
Jun 24

CStone Pharmaceuticals shareholders pass AGM resolutions

Reuters
·
Jun 24

CSTONE PHARMA-B Repurchases 500,000 Shares for HK$2.35 Million

Stock News
·
Jun 22

CStone Pharmaceuticals files HKEX next-day disclosure, reports share repurchase for cancellation

Reuters
·
Jun 22

CStone Pharmaceuticals repurchases 500,000 shares at up to HK$4.63; June buybacks total 2.84 million shares

Bulletin Express
·
Jun 18

CStone Pharmaceuticals-B Repurchases 500,000 Shares for HK$2.3143 Million on June 18

Stock News
·
Jun 18

CStone files HKEX next-day disclosure return, reports share repurchase for cancellation

Reuters
·
Jun 18

CStone Pharmaceuticals Repurchases 1.00 Million Shares on 17 June; Cumulative Buyback Reaches 2.34 Million Shares

Bulletin Express
·
Jun 17

Directors and Company Execute Major Share Purchases and Buyback at CSTONE PHARMA-B

Stock News
·
Jun 17

CStone Pharma repurchases 1.33 million shares for HK$6.23 million, equal to 0.08% of share capital

Bulletin Express
·
Jun 16

CSTONE PHARMA-B Repurchases 1.33 Million Shares for HK$6.2278 Million on June 16

Stock News
·
Jun 16

CStone files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 16

CStone says 4,270,000 RSU grant to CEO Yang needs independent shareholder approval under HK rules

Reuters
·
Jun 16

CStone proposes 7 million stock options, 4.27 million RSUs for CEO Yang Jianxin

Reuters
·
Jun 16

CStone Pharmaceuticals-B Executes Share Buyback, Spending HK$28,000 on June 15

Stock News
·
Jun 15

CStone files HKEX next-day disclosure return after share repurchase for cancellation at HKD 4.66

Reuters
·
Jun 15